Skip to content

Absci Corporation ABSI Restricted Cash

Restricted Cash at other companies

Schrodinger logo
SchrodingerSDGR
$7.46M-36.6%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$5.51M+79.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$25M0.0%
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
$3.04M0.0%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$2.22M+6.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's restricted cash?
Absci Corporation (ABSI) reported restricted cash of $1.06M in Q1 2026.
How has Absci Corporation's restricted cash changed year-over-year?
Absci Corporation's restricted cash decreased by 93.4% year-over-year, from $16.08M to $1.06M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.